Adagio Medical Holdings, Inc. - 8-K Summary
Business Context and Reporting Period
This Form 8-K reports the results of the 2026 Annual Meeting of Stockholders held on June 16, 2026. Adagio Medical Holdings, Inc. is an emerging growth company incorporated in Delaware, with its common stock (ADGM) trading on The Nasdaq Stock Market LLC.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and voting results.
Material Changes and Voting Results
Of the 22,210,459 shares outstanding, 16,069,984 shares (72.35%) were present or represented by proxy. Two proposals were submitted and approved:
- Proposal 1: Election of Directors
- Orly Mishan: Elected with 11,930,745 votes For, 1,396,139 Withheld, and 2,743,100 Broker Non-Votes.
- Sean Salmon: Elected with 13,322,425 votes For, 4,459 Withheld, and 2,743,100 Broker Non-Votes.
- Proposal 2: Ratification of Auditors
- WithumSmith+Brown, PC was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
- Votes: 16,055,195 For, 14,081 Against, 708 Abstain, and 0 Broker Non-Votes.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document serves solely to disclose the outcome of the stockholder vote.
Key Facts for Investor Verification
- Verify the tenure of the newly elected directors (Orly Mishan and Sean Salmon) until the 2029 annual meeting.
- Confirm the appointment of WithumSmith+Brown, PC as the auditor for the fiscal year ending December 31, 2026.
- Note the high level of broker non-votes (2,743,100) on the director election, indicating shares held by brokers that did not receive voting instructions.